GLP-1 receptor agonists show promise in reducing binge eating behaviors in disorders like bulimia nervosa, offering a new avenue for treatment with minimal side effects.
New hope for binge eating and bulimia: GLP-1 drugs could be the key
- Post author:
- Post published:March 4, 2024
- Post category:uncategorized